Spoken Alpha
LGNZZ
LIGAND PHARMACEUTICALS INC
Overview
Ligand Pharmaceuticals operates as a biopharmaceutical royalty company that acquires and structures royalty interests in mid- to late-stage development and commercial drug products, generating long-duration cash flows from partner-commercialized medicines.
LIGAND PHARMACEUTICALS INC has a $10.9M market cap.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from SEC 10-K filing, 2026-08-30.
Transcripts
Recent earnings calls
No earnings calls indexed for LGNZZ yet
We index calls for roughly 3,000 US-listed companies. If you'd like us to add LGNZZ, reply to your welcome email and we'll prioritize it.
History
Earnings history
Reported quarters with consensus, surprise, and 1-day reaction context.
Top executives
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for LGNZZ.
$ curl https://api.spokenalpha.com/v1/companies/LGNZZFAQ
Frequently asked about LGNZZ
Where can I find LIGAND PHARMACEUTICALS INC's (LGNZZ) earnings call transcripts?
Spoken Alpha indexes LGNZZ's earnings call transcripts at https://spokenalpha.com/companies/LGNZZ. Each call links to attributed speakers and parsed analyst Q&A. LIGAND PHARMACEUTICALS INC's own investor relations page is at https://investor.ligand.com/overview/default.aspx.